Invokana can significantly reduce heart events in type 2 diabetes patients but doubles risk for toe and lower foot amputations. How does Johnson & Johnson's Invokana fare compared with rival drug Jardiance?
J&J Drug May Reduce Heart Events In Diabetes Patients But Doubles Risk For Toe, Lower Foot Amputations
Tech Times - 13 Jun 2017 13:23
Invokana can significantly reduce heart events in type 2 diabetes patients but doubles risk for toe and lower foot amputations. How does Johnson & Johnson's Invokana fare compared with rival drug Jardiance?
Share this Article
Recommended